Global Drugs for Traveler's Diarrhea Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Drugs for Traveler's Diarrhea market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Drugs for Traveler's Diarrhea is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Drugs for Traveler's Diarrhea is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Drugs for Traveler's Diarrhea is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Drugs for Traveler's Diarrhea is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Drugs for Traveler's Diarrhea include GSK, Sigmoid Pharma, Scandinavian Biopharma, Salix Pharmaceuticals, Prokarium Limited, Nippon Shinyaku, Cosmo Pharmaceuticals and Chiesi Farmaceutici, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Drugs for Traveler's Diarrhea, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Drugs for Traveler's Diarrhea, also provides the sales of main regions and countries. Of the upcoming market potential for Drugs for Traveler's Diarrhea, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drugs for Traveler's Diarrhea sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Drugs for Traveler's Diarrhea market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Drugs for Traveler's Diarrhea sales, projected growth trends, production technology, application and end-user industry.

Drugs for Traveler's Diarrhea Segment by Company

GSK
Sigmoid Pharma
Scandinavian Biopharma
Salix Pharmaceuticals
Prokarium Limited
Nippon Shinyaku
Cosmo Pharmaceuticals
Chiesi Farmaceutici

Drugs for Traveler's Diarrhea Segment by Type

Antibiotics
Anti-motility agents
Bismuth Subsalicylate (Pepto-Bismol)

Drugs for Traveler's Diarrhea Segment by Application

Adult
Children

Drugs for Traveler's Diarrhea Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Traveler's Diarrhea market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Traveler's Diarrhea and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Traveler's Diarrhea.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Drugs for Traveler's Diarrhea in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Drugs for Traveler's Diarrhea manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Traveler's Diarrhea sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Drugs for Traveler's Diarrhea Market by Type
1.2.1 Global Drugs for Traveler's Diarrhea Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Antibiotics
1.2.3 Anti-motility agents
1.2.4 Bismuth Subsalicylate (Pepto-Bismol)
1.3 Drugs for Traveler's Diarrhea Market by Application
1.3.1 Global Drugs for Traveler's Diarrhea Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Adult
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Drugs for Traveler's Diarrhea Market Dynamics
2.1 Drugs for Traveler's Diarrhea Industry Trends
2.2 Drugs for Traveler's Diarrhea Industry Drivers
2.3 Drugs for Traveler's Diarrhea Industry Opportunities and Challenges
2.4 Drugs for Traveler's Diarrhea Industry Restraints
3 Global Market Growth Prospects
3.1 Global Drugs for Traveler's Diarrhea Revenue Estimates and Forecasts (2020-2031)
3.2 Global Drugs for Traveler's Diarrhea Revenue by Region
3.2.1 Global Drugs for Traveler's Diarrhea Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Drugs for Traveler's Diarrhea Revenue by Region (2020-2025)
3.2.3 Global Drugs for Traveler's Diarrhea Revenue by Region (2026-2031)
3.2.4 Global Drugs for Traveler's Diarrhea Revenue Market Share by Region (2020-2031)
3.3 Global Drugs for Traveler's Diarrhea Sales Estimates and Forecasts 2020-2031
3.4 Global Drugs for Traveler's Diarrhea Sales by Region
3.4.1 Global Drugs for Traveler's Diarrhea Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Drugs for Traveler's Diarrhea Sales by Region (2020-2025)
3.4.3 Global Drugs for Traveler's Diarrhea Sales by Region (2026-2031)
3.4.4 Global Drugs for Traveler's Diarrhea Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Drugs for Traveler's Diarrhea Revenue by Manufacturers
4.1.1 Global Drugs for Traveler's Diarrhea Revenue by Manufacturers (2020-2025)
4.1.2 Global Drugs for Traveler's Diarrhea Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Drugs for Traveler's Diarrhea Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Drugs for Traveler's Diarrhea Sales by Manufacturers
4.2.1 Global Drugs for Traveler's Diarrhea Sales by Manufacturers (2020-2025)
4.2.2 Global Drugs for Traveler's Diarrhea Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Drugs for Traveler's Diarrhea Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Drugs for Traveler's Diarrhea Sales Price by Manufacturers (2020-2025)
4.4 Global Drugs for Traveler's Diarrhea Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Drugs for Traveler's Diarrhea Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Drugs for Traveler's Diarrhea Manufacturers, Product Type & Application
4.7 Global Drugs for Traveler's Diarrhea Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Drugs for Traveler's Diarrhea Market CR5 and HHI
4.8.2 2024 Drugs for Traveler's Diarrhea Tier 1, Tier 2, and Tier 3
5 Drugs for Traveler's Diarrhea Market by Type
5.1 Global Drugs for Traveler's Diarrhea Revenue by Type
5.1.1 Global Drugs for Traveler's Diarrhea Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Drugs for Traveler's Diarrhea Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Drugs for Traveler's Diarrhea Revenue Market Share by Type (2020-2031)
5.2 Global Drugs for Traveler's Diarrhea Sales by Type
5.2.1 Global Drugs for Traveler's Diarrhea Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Drugs for Traveler's Diarrhea Sales by Type (2020-2031) & (W Units)
5.2.3 Global Drugs for Traveler's Diarrhea Sales Market Share by Type (2020-2031)
5.3 Global Drugs for Traveler's Diarrhea Price by Type
6 Drugs for Traveler's Diarrhea Market by Application
6.1 Global Drugs for Traveler's Diarrhea Revenue by Application
6.1.1 Global Drugs for Traveler's Diarrhea Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Drugs for Traveler's Diarrhea Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Drugs for Traveler's Diarrhea Revenue Market Share by Application (2020-2031)
6.2 Global Drugs for Traveler's Diarrhea Sales by Application
6.2.1 Global Drugs for Traveler's Diarrhea Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Drugs for Traveler's Diarrhea Sales by Application (2020-2031) & (W Units)
6.2.3 Global Drugs for Traveler's Diarrhea Sales Market Share by Application (2020-2031)
6.3 Global Drugs for Traveler's Diarrhea Price by Application
7 Company Profiles
7.1 GSK
7.1.1 GSK Comapny Information
7.1.2 GSK Business Overview
7.1.3 GSK Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 GSK Drugs for Traveler's Diarrhea Product Portfolio
7.1.5 GSK Recent Developments
7.2 Sigmoid Pharma
7.2.1 Sigmoid Pharma Comapny Information
7.2.2 Sigmoid Pharma Business Overview
7.2.3 Sigmoid Pharma Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Sigmoid Pharma Drugs for Traveler's Diarrhea Product Portfolio
7.2.5 Sigmoid Pharma Recent Developments
7.3 Scandinavian Biopharma
7.3.1 Scandinavian Biopharma Comapny Information
7.3.2 Scandinavian Biopharma Business Overview
7.3.3 Scandinavian Biopharma Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Scandinavian Biopharma Drugs for Traveler's Diarrhea Product Portfolio
7.3.5 Scandinavian Biopharma Recent Developments
7.4 Salix Pharmaceuticals
7.4.1 Salix Pharmaceuticals Comapny Information
7.4.2 Salix Pharmaceuticals Business Overview
7.4.3 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio
7.4.5 Salix Pharmaceuticals Recent Developments
7.5 Prokarium Limited
7.5.1 Prokarium Limited Comapny Information
7.5.2 Prokarium Limited Business Overview
7.5.3 Prokarium Limited Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Prokarium Limited Drugs for Traveler's Diarrhea Product Portfolio
7.5.5 Prokarium Limited Recent Developments
7.6 Nippon Shinyaku
7.6.1 Nippon Shinyaku Comapny Information
7.6.2 Nippon Shinyaku Business Overview
7.6.3 Nippon Shinyaku Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Nippon Shinyaku Drugs for Traveler's Diarrhea Product Portfolio
7.6.5 Nippon Shinyaku Recent Developments
7.7 Cosmo Pharmaceuticals
7.7.1 Cosmo Pharmaceuticals Comapny Information
7.7.2 Cosmo Pharmaceuticals Business Overview
7.7.3 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio
7.7.5 Cosmo Pharmaceuticals Recent Developments
7.8 Chiesi Farmaceutici
7.8.1 Chiesi Farmaceutici Comapny Information
7.8.2 Chiesi Farmaceutici Business Overview
7.8.3 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Product Portfolio
7.8.5 Chiesi Farmaceutici Recent Developments
8 North America
8.1 North America Drugs for Traveler's Diarrhea Market Size by Type
8.1.1 North America Drugs for Traveler's Diarrhea Revenue by Type (2020-2031)
8.1.2 North America Drugs for Traveler's Diarrhea Sales by Type (2020-2031)
8.1.3 North America Drugs for Traveler's Diarrhea Price by Type (2020-2031)
8.2 North America Drugs for Traveler's Diarrhea Market Size by Application
8.2.1 North America Drugs for Traveler's Diarrhea Revenue by Application (2020-2031)
8.2.2 North America Drugs for Traveler's Diarrhea Sales by Application (2020-2031)
8.2.3 North America Drugs for Traveler's Diarrhea Price by Application (2020-2031)
8.3 North America Drugs for Traveler's Diarrhea Market Size by Country
8.3.1 North America Drugs for Traveler's Diarrhea Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Drugs for Traveler's Diarrhea Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Drugs for Traveler's Diarrhea Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Drugs for Traveler's Diarrhea Market Size by Type
9.1.1 Europe Drugs for Traveler's Diarrhea Revenue by Type (2020-2031)
9.1.2 Europe Drugs for Traveler's Diarrhea Sales by Type (2020-2031)
9.1.3 Europe Drugs for Traveler's Diarrhea Price by Type (2020-2031)
9.2 Europe Drugs for Traveler's Diarrhea Market Size by Application
9.2.1 Europe Drugs for Traveler's Diarrhea Revenue by Application (2020-2031)
9.2.2 Europe Drugs for Traveler's Diarrhea Sales by Application (2020-2031)
9.2.3 Europe Drugs for Traveler's Diarrhea Price by Application (2020-2031)
9.3 Europe Drugs for Traveler's Diarrhea Market Size by Country
9.3.1 Europe Drugs for Traveler's Diarrhea Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Drugs for Traveler's Diarrhea Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Drugs for Traveler's Diarrhea Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Drugs for Traveler's Diarrhea Market Size by Type
10.1.1 China Drugs for Traveler's Diarrhea Revenue by Type (2020-2031)
10.1.2 China Drugs for Traveler's Diarrhea Sales by Type (2020-2031)
10.1.3 China Drugs for Traveler's Diarrhea Price by Type (2020-2031)
10.2 China Drugs for Traveler's Diarrhea Market Size by Application
10.2.1 China Drugs for Traveler's Diarrhea Revenue by Application (2020-2031)
10.2.2 China Drugs for Traveler's Diarrhea Sales by Application (2020-2031)
10.2.3 China Drugs for Traveler's Diarrhea Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Drugs for Traveler's Diarrhea Market Size by Type
11.1.1 Asia Drugs for Traveler's Diarrhea Revenue by Type (2020-2031)
11.1.2 Asia Drugs for Traveler's Diarrhea Sales by Type (2020-2031)
11.1.3 Asia Drugs for Traveler's Diarrhea Price by Type (2020-2031)
11.2 Asia Drugs for Traveler's Diarrhea Market Size by Application
11.2.1 Asia Drugs for Traveler's Diarrhea Revenue by Application (2020-2031)
11.2.2 Asia Drugs for Traveler's Diarrhea Sales by Application (2020-2031)
11.2.3 Asia Drugs for Traveler's Diarrhea Price by Application (2020-2031)
11.3 Asia Drugs for Traveler's Diarrhea Market Size by Country
11.3.1 Asia Drugs for Traveler's Diarrhea Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Drugs for Traveler's Diarrhea Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Drugs for Traveler's Diarrhea Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Drugs for Traveler's Diarrhea Market Size by Type
12.1.1 SAMEA Drugs for Traveler's Diarrhea Revenue by Type (2020-2031)
12.1.2 SAMEA Drugs for Traveler's Diarrhea Sales by Type (2020-2031)
12.1.3 SAMEA Drugs for Traveler's Diarrhea Price by Type (2020-2031)
12.2 SAMEA Drugs for Traveler's Diarrhea Market Size by Application
12.2.1 SAMEA Drugs for Traveler's Diarrhea Revenue by Application (2020-2031)
12.2.2 SAMEA Drugs for Traveler's Diarrhea Sales by Application (2020-2031)
12.2.3 SAMEA Drugs for Traveler's Diarrhea Price by Application (2020-2031)
12.3 SAMEA Drugs for Traveler's Diarrhea Market Size by Country
12.3.1 SAMEA Drugs for Traveler's Diarrhea Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Drugs for Traveler's Diarrhea Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Drugs for Traveler's Diarrhea Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Drugs for Traveler's Diarrhea Value Chain Analysis
13.1.1 Drugs for Traveler's Diarrhea Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Drugs for Traveler's Diarrhea Production Mode & Process
13.2 Drugs for Traveler's Diarrhea Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Drugs for Traveler's Diarrhea Distributors
13.2.3 Drugs for Traveler's Diarrhea Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings